BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15928216)

  • 1. Human subjects issues and IRB review in practice-based research.
    Wolf LE; Walden JF; Lo B
    Ann Fam Med; 2005; 3 Suppl 1(Suppl 1):S30-7. PubMed ID: 15928216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Working with the institutional review board.
    Byerly WG
    Am J Health Syst Pharm; 2009 Jan; 66(2):176-84. PubMed ID: 19139484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The challenges of IRB review and human subjects protections in practice-based research.
    Wolf LE; Croughan M; Lo B
    Med Care; 2002 Jun; 40(6):521-9. PubMed ID: 12021678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Institutional Review Boards: What Clinician Researchers Need to Know.
    Lapid MI; Clarke BL; Wright RS
    Mayo Clin Proc; 2019 Mar; 94(3):515-525. PubMed ID: 30832791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The purpose, composition, and function of an institutional review board: balancing priorities.
    Enfield KB; Truwit JD
    Respir Care; 2008 Oct; 53(10):1330-6. PubMed ID: 18811996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burdens on research imposed by institutional review boards: the state of the evidence and its implications for regulatory reform.
    Silberman G; Kahn KL
    Milbank Q; 2011 Dec; 89(4):599-627. PubMed ID: 22188349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice-based research network studies and institutional review boards: two new issues.
    Yawn BP; Graham DG; Bertram SL; Kurland MJ; Dietrich AJ; Wollan PC; Brandt EC; Huff JM; Pace WD
    J Am Board Fam Med; 2009; 22(4):453-60. PubMed ID: 19587261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
    Bramstedt KA; Kassimatis K
    Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice-based research network studies in the age of HIPAA.
    Pace WD; Staton EW; Holcomb S
    Ann Fam Med; 2005; 3 Suppl 1(Suppl 1):S38-45. PubMed ID: 15928217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Institutional review board barriers and solutions encountered in the Collaboration Among Pharmacists and Physicians to Improve Outcomes Now Study: a national multicenter practice-based implementation trial.
    Maclaughlin EJ; Ardery G; Jackson EA; Ives TJ; Young RB; Fike DS; Carter BL
    Pharmacotherapy; 2013 Sep; 33(9):902-11. PubMed ID: 23649880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to do human-subjects research if you do not have an institutional review board.
    Rice TW
    Respir Care; 2008 Oct; 53(10):1362-7. PubMed ID: 18812001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Institutional Review Boards: Purpose and Challenges.
    Grady C
    Chest; 2015 Nov; 148(5):1148-1155. PubMed ID: 26042632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsible conduct of radiology research: part II. Regulatory requirements for human research.
    Cooper JA
    Radiology; 2005 Sep; 236(3):748-52. PubMed ID: 16118157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRB practices and policies regarding the secondary research use of biospecimens.
    Goldenberg AJ; Maschke KJ; Joffe S; Botkin JR; Rothwell E; Murray TH; Anderson R; Deming N; Rosenthal BF; Rivera SM
    BMC Med Ethics; 2015 May; 16():32. PubMed ID: 25953109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IRB challenge for practice-based research: strategies of the American Academy of Family Physicians National Research Network (AAFP NRN).
    Graham DG; Spano MS; Manning B
    J Am Board Fam Med; 2007; 20(2):181-7. PubMed ID: 17341755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigators' successful strategies for working with Institutional Review Boards.
    Cartwright JC; Hickman SE; Nelson CA; Knafl KA
    Res Nurs Health; 2013 Oct; 36(5):478-86. PubMed ID: 23813748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Protecting" or "Policing": Academic Researchers' View of IRBs in an Arab Context.
    Makhoul J; El-Alti L; Qutteina Y; Nasrallah C; Sakr C; Nakkash R; Alali K
    J Empir Res Hum Res Ethics; 2014 Dec; 9(5):25-35. PubMed ID: 25747688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining risk in pediatric research with no prospect of direct benefit: time for a national consensus on the interpretation of federal regulations.
    Fisher CB; Kornetsky SZ; Prentice ED
    Am J Bioeth; 2007 Mar; 7(3):5-10. PubMed ID: 17366219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of local institutional review board review on participation in national practice-based research network studies.
    Finch SA; Barkin SL; Wasserman RC; Dhepyasuwan N; Slora EJ; Sege RD
    Arch Pediatr Adolesc Med; 2009 Dec; 163(12):1130-4. PubMed ID: 19996050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.